All In Biotech

Drug Trial Radar · NCT06476509

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

A Non-Randomized, Open-Label, Exploratory Mechanistic Validation (PoM) Clinical Trial of LV232 Capsule Assessing Serotonin Transporter Occupancy in the Healthy Adult Brain Using 11C-DASB Positron Emission Tomography (PET)

Last checked: Nov 19, 2026Latest source record: Jun 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

May 30, 2024

Primary completion

Jan 19, 2025

Study completion May 23, 2025

Sponsor

Lead sponsor
Vigonvita Life SciencesIndustry
Sponsor type
Industry
First posted
Jun 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study was a non-randomized, open-label clinical study to assess Serotonin transporter occupancy in the brain of healthy adults using 11C-DASB positron emission tomography (PET)

Conditions

  • Major Depressive Disorder

Interventions

  • LV232 40mgDrug

    oral

  • Escitalopram 20 mgDrug

    oral

  • LV232 60mgDrug

    oral

  • LV232 20mgDrug

    oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serotonin Transporters occupancyTime frame: baseline and 3 hours after administration on Day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Mental Health Center Ethics Committee

    Shanghai, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.